To evaluate the potential of 225Ac-PSMA617 for PSMA-targeting alpha-therapy of poor-prognosis advanced-stage mCRPC patients.
KRATOCHWIL Clemens;
BRUCHERTSEIFER Frank;
GIESEL Frederik;
APOSTOLIDIS Christos;
HABERKORN Uwe;
MORGENSTERN Alfred;
2017-10-25
SPRINGER
JRC106777
1619-7070,
https://link.springer.com/journal/259/44/2/suppl/page/1,
https://publications.jrc.ec.europa.eu/repository/handle/JRC106777,
| Name | Country | City | Type |
|---|
This document is only visible at the Commission level.
You are not authorized to publish or distribute it outside the European Commission.
This is a public document. You can share this publication.
Datasets
| ID | Title | Public URL |
|---|
Dataset collections
| ID | Acronym | Title | Public URL |
|---|
Scripts / source codes
| Description | Public URL |
|---|
Additional supporting files
| File name | Description | File type |
|---|